Failures at 10-week outcome measurement
| Study number | Reason for failure |
|---|---|
| 102 | Inefficacy, uncontrolled inflammation |
| 104 | Inefficacy |
| 106 | Inefficacy; uncontrolled inflammation, new KP |
| 108 | Inefficacy; symptomatically worse |
| 112 | Inefficacy, inflammation uncontrolled study drug and high dose corticosteroids, dc at week 6 |
| 114 | Inefficacy; uncontrolled inflammation |
| 116 | Inefficacy; worsened macular oedema with steroid taper |
| 205 | Inefficacy; uncontrolled inflammation |
| 206 | Inefficacy; uncontrolled inflammation |
| 302 | Hypoglycaemic/diabetic coma at week 10 |
dc, discontinue; KP, keratic precipitates.